Skip to main content
HBIO logo

HBIO · Harvard Bioscience Inc · Held by Funds

Track HBIO — free
$8.35 +0.03 (+0.36%) At close · Oct 27 Q2 2026 earnings call transcript
Market Cap
$38.01M
Shares
4.55M
Volume · Oct 27 6053 Avg daily vol (3M) 18.42K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of HBIO by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 4.69% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 1.05% 47,780
Index ETFs 3.64% 165,513
Active ETFs 0.05% 2,395
Active funds 0.42% 18,952
Unclassified 0.00% 0
All registered funds 5.15% 234,640
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding HBIO

24 fund positions
Fund Balance Value % of Fund Open
Showing 1–24 of 24 positions
Key facts CIK 1123494 CUSIP 416906204 13F (30d) 6 filings 6 filers Visit website Investor relations